Error: Could not add to watchlist. X

Synageva BioPharma Corp

+ Watchlist
GEVA:US
NASDAQ GS
215.56
USD
2.53
1.16%
As of 15:53:53 ET on 06/03/2015.
Open
218.62
Day Range
215.10 - 218.62
Volume
828,172
Previous Close
218.09
52Wk Range
60.19 - 219.30
1 Yr Return
175.14%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-6.34
Market Cap (b USD)
8.045
Shares Outstanding (m)
37.163
Price/Sales (TTM)
1,243.06
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.
ADDRESS
128 Spring Street
Suite 520
Lexington, MA 02421
United States
PHONE
1-781-357-9900
  • Sanj K Patel
    President/CEO
  • Robert Bazemore "Rob"
    Chief Operating Officer
  • Anthony G Quinn
    Exec VP/Chief Medical Officer
  • Carsten Boess
    Senior VP/CFO
  • Glen Williams
    Senior VP:Global Technical Ops
Show More